Immune Response of Haemodialysis Patients Post Covid-19 Vaccination

NCT04872751 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 425

Last updated 2021-05-07

No results posted yet for this study

Summary

The purpose of this study is to assess immune response of end stage renal failure patients after Covid 19 vaccination

Conditions

  • Immune Response Post Covid 19 Vaccination

Sponsors & Collaborators

  • Penang Hospital, Malaysia

    lead OTHER_GOV

Principal Investigators

  • LokeMeng Ong · Penang Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-04-27
Primary Completion
2022-04-30
Completion
2022-04-30

Countries

  • Malaysia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04872751 on ClinicalTrials.gov